Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (a type of cancer affecting the lining of the abdomen), either first diagnosed after January 2015 or as a cancer that came back and responded to platinum-based chemotherapy, and you received a type of maintenance treatment called a PARP inhibitor by January 2024
- You are a woman aged 18 or older
- Before starting PARP inhibitor treatment, your blood protein marker (CA125) was stable, your general health score was within an acceptable range (meaning you were able to carry out daily activities), and your heart, liver, and kidneys were working well enough
Who may not be able to join:
- You have been diagnosed with another type of cancer within the last 5 years
- Your overall health is considered poor — for example, if you have significant difficulty with daily activities, or have serious heart, liver, or kidney problems (confirm with trial site for specific scoring details)
- The biological samples (such as blood or tissue) available from you are not sufficient in amount or quality for the required testing
- You have any other condition that the trial doctor believes could affect how the study is run or how the results are interpreted (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
HRD score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.